Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

BACKGROUND: In the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study, Cladribine Tablets significantly improved clinical and magnetic resonance imaging (MRI) outcomes (vs placebo) in patients with relapsing-remitting multiple sclerosis. OBJECTIVE: Describe two clinically relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil W, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Hicking, Christine, Vermersch, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460686/
https://www.ncbi.nlm.nih.gov/pubmed/29716436
http://dx.doi.org/10.1177/1352458518771875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460686/
https://www.ncbi.nlm.nih.gov/pubmed/29716436
http://dx.doi.org/10.1177/1352458518771875

Ejemplares similares